Shiyan Li Selected Research

Topical Administration

1/2023

ceAF Ameliorates Diabetic Wound Healing by Alleviating Inflammation and Oxidative Stress via TLR4/NF-κB and Nrf2 Pathways.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shiyan Li Research Topics

Disease

7	Wounds and Injuries (Trauma) 01/2023 - 01/2014
6	Neoplasms (Cancer) 12/2022 - 03/2006
3	Inflammation (Inflammations) 01/2023 - 05/2022
3	Stomach Neoplasms (Stomach Cancer) 01/2022 - 04/2011
2	Shock 10/2022 - 01/2019
2	Burns 10/2022 - 01/2019
2	Melanoma (Melanoma, Malignant) 03/2020 - 01/2020
1	Myeloid Leukemia (Leukemia, Myelocytic) 01/2024
1	Ulcer 01/2024
1	Hyperglycemia 01/2024
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023
1	Adenocarcinoma 01/2023
1	Carcinosarcoma 01/2023
1	Dysmenorrhea (Menstrual Pain) 01/2023
1	Lung Neoplasms (Lung Cancer) 01/2023
1	Pancreatic Neoplasms (Pancreatic Cancer) 02/2022
1	Poisoning 12/2021
1	Infections 04/2021
1	Compression Fractures (Compression Fracture) 08/2015
1	Carcinoma (Carcinomatosis) 07/2013
1	Colonic Neoplasms (Colon Cancer) 07/2013
1	Heart Diseases (Heart Disease) 08/2003
1	Insulin Resistance 08/2003

Drug/Important Bio-Agent (IBA)

4	CollagenIBA 01/2023 - 01/2014
2	Therapeutic UsesIBA 01/2024 - 01/2023
2	TriterpenesIBA 01/2024 - 01/2023
2	urinastatin (MR 20)IBA 10/2022 - 01/2019
2	VemurafenibIBA 03/2020 - 01/2020
1	AntioxidantsIBA 01/2024
1	Sincalide FDA Link 01/2024
1	HydrogelsIBA 01/2023
1	Hyaluronic Acid (Hyaluronan)IBA 01/2023
1	ErbB Receptors (EGF Receptor)IBA 01/2023
1	Long Noncoding RNAIBA 01/2023
1	Tyrosine Kinase InhibitorsIBA 01/2023
1	ProstaglandinsIBA 01/2023
1	osimertinibIBA 01/2023
1	Oxytocin (Pitocin)FDA LinkGeneric 01/2023
1	2-(4-toluidino)-6-naphthalenesulfonic acid (TNS)IBA 12/2022
1	InterleukinsIBA 05/2022
1	CateninsIBA 02/2022
1	Small Interfering RNA (siRNA)IBA 02/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	NLR ProteinsIBA 01/2022
1	puerarinIBA 01/2022
1	MicroRNAs (MicroRNA)IBA 01/2022
1	InflammasomesIBA 01/2022
1	Antineoplastic Agents (Antineoplastics)IBA 01/2022
1	Sulfates (Sulfates, Inorganic)IBA 12/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2021
1	norvancomycinIBA 04/2021
1	GlycopeptidesIBA 04/2021
1	Vancomycin FDA LinkGeneric 04/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 03/2020
1	Sorafenib (BAY 43-9006)FDA Link 03/2020
1	Peptides (Polypeptides)IBA 01/2014
1	Fluorescent Dyes (Fluorescent Probes)IBA 07/2013
1	ChromatinIBA 07/2013
1	Contrast MediaIBA 04/2011
1	Eosine Yellowish-(YS) (Eosin)IBA 04/2011
1	Periodic AcidIBA 04/2011
1	Alcian BlueIBA 04/2011
1	Cisplatin (Platino)FDA LinkGeneric 03/2006
1	Glucose (Dextrose)FDA LinkGeneric 08/2003

Therapy/Procedure

4	Therapeutics 01/2023 - 01/2014
4	Drug Therapy (Chemotherapy) 01/2023 - 03/2006
2	Microbubbles 02/2022 - 07/2013
1	Topical Administration 01/2023
1	Surgical Amputation (Amputations) 02/2022
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022
1	Duration of Therapy 01/2020
1	Kyphoplasty 08/2015
1	Vertebroplasty 08/2015
1	Gastrectomy 01/2013